Mizuho Securities lifted its price target and disclosed a transaction involving Guardant Health in an SEC filing.
1 report, 1 independent
Updated Aug 18
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Mizuho Securities lifted its price target and disclosed a transaction involving Guardant Health in an SEC filing.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Guardant Health
American biotechnology company
Nothing else this week.
-
Mizuho Securities
Japanese investment banking company
Nothing else this week.
-
SEC
Slovak company
Related events
- Mizuho Securities raised its price target on Dell Technologies.
- Mizuho Securities raised its price target for Highwoods Properties (HIW) on July 23, 2026.
- Mizuho Securities raised its price target for Element Solutions Inc. on October 22, 2026.
- Mizuho Securities lowered its price target on Lam Research stock, while Berenberg Bank set a high target and Citigroup reiterated a buy rating.
- Multiple analyst firms, including Needham, Mizuho, and Zacks, issued rating changes and coverage updates for Harmony Biosciences.